India · Delayed Price · Currency is INR Accretion Pharmaceuticals Statistics
Total Valuation
NSE:ACCPL has a market cap or net worth of INR 2.25 billion. The enterprise value is 2.40 billion.
| Market Cap | 2.25B |
| Enterprise Value | 2.40B |
Important Dates
The last earnings date was Saturday, October 31, 2026.
| Earnings Date | Oct 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:ACCPL has 11.12 million shares outstanding. The number of shares has increased by 20.14% in one year.
| Current Share Class | 11.12M |
| Shares Outstanding | 11.12M |
| Shares Change (YoY) | +20.14% |
| Shares Change (QoQ) | +7.68% |
| Owned by Insiders (%) | 73.50% |
| Owned by Institutions (%) | n/a |
| Float | 2.95M |
Valuation Ratios
The trailing PE ratio is 17.15.
| PE Ratio | 17.15 |
| Forward PE | n/a |
| PS Ratio | 2.23 |
| PB Ratio | 3.58 |
| P/TBV Ratio | 3.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 18.28 |
| EV / Sales | 2.37 |
| EV / EBITDA | 11.84 |
| EV / EBIT | 12.91 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.70, with a Debt / Equity ratio of 0.27.
| Current Ratio | 3.70 |
| Quick Ratio | 1.81 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | n/a |
| Interest Coverage | 18.16 |
Financial Efficiency
Return on equity (ROE) is 23.96% and return on invested capital (ROIC) is 17.93%.
| Return on Equity (ROE) | 23.96% |
| Return on Assets (ROA) | 15.85% |
| Return on Invested Capital (ROIC) | 17.93% |
| Return on Capital Employed (ROCE) | 27.11% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 7.65M |
| Profits Per Employee | 993,689 |
| Employee Count | 132 |
| Asset Turnover | 1.38 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, NSE:ACCPL has paid 44.01 million in taxes.
| Income Tax | 44.01M |
| Effective Tax Rate | 25.12% |
Stock Price Statistics
The stock price has increased by +256.83% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +256.83% |
| 50-Day Moving Average | 200.76 |
| 200-Day Moving Average | 133.60 |
| Relative Strength Index (RSI) | 53.99 |
| Average Volume (20 Days) | 15,360 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ACCPL had revenue of INR 1.01 billion and earned 131.17 million in profits. Earnings per share was 11.81.
| Revenue | 1.01B |
| Gross Profit | 299.67M |
| Operating Income | 185.65M |
| Pretax Income | 175.17M |
| Net Income | 131.17M |
| EBITDA | 202.51M |
| EBIT | 185.65M |
| Earnings Per Share (EPS) | 11.81 |
Balance Sheet
The company has 21.27 million in cash and 167.37 million in debt, with a net cash position of -146.10 million or -13.14 per share.
| Cash & Cash Equivalents | 21.27M |
| Total Debt | 167.37M |
| Net Cash | -146.10M |
| Net Cash Per Share | -13.14 |
| Equity (Book Value) | 629.10M |
| Book Value Per Share | 56.61 |
| Working Capital | 510.67M |
Cash Flow
In the last 12 months, operating cash flow was -20.70 million and capital expenditures -80.98 million, giving a free cash flow of -101.68 million.
| Operating Cash Flow | -20.70M |
| Capital Expenditures | -80.98M |
| Depreciation & Amortization | 16.86M |
| Net Borrowing | 88.81M |
| Free Cash Flow | -101.68M |
| FCF Per Share | -9.15 |
Margins
Gross margin is 29.68%, with operating and profit margins of 18.39% and 12.99%.
| Gross Margin | 29.68% |
| Operating Margin | 18.39% |
| Pretax Margin | 17.35% |
| Profit Margin | 12.99% |
| EBITDA Margin | 20.06% |
| EBIT Margin | 18.39% |
| FCF Margin | n/a |
Dividends & Yields
NSE:ACCPL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -20.14% |
| Shareholder Yield | -20.14% |
| Earnings Yield | 5.83% |
| FCF Yield | -4.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |